B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nifuratel

94 PubMed studies analyzed ยท 8 RCTs ยท Evidence Score: 46.3

Research Domains

Nifuratel has been studied across 6 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿซ Liver & Detox, ๐Ÿฆ  Gut & Microbiome, โšก Energy & Fatigue, ๐Ÿ’Š Pain. The primary research focus is ๐Ÿ”ฌ Oncology with 3% of studies addressing this area.

Loading evidence profile...

This evidence profile for Nifuratel is generated deterministically from 94 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.